πŸ‡ΊπŸ‡Έ FDA
Patent

US 10568871

Triazolone compounds and uses thereof

granted A61KA61K31/41A61K31/4196

Quick answer

US patent 10568871 (Triazolone compounds and uses thereof) held by TEMPEST THERAPEUTICS, INC. expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEMPEST THERAPEUTICS, INC.
Grant date
Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/41, A61K31/4196, A61K31/4439, A61K31/506